Clinical Trial: This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Recurrent Prostate Cancer After Surgery
Study Type: INTERVENTIONAL
Official Title: Daily-Adaptive Stereotactic Body Radiation Therapy for Biochemically Recurrent, Radiologic Apparent Prostate Cancer After Radical Prostatectomy
Brief Summary:
There is significant, proven use of radiation for recurrent prostate cancer after surgical resection.This treatment typically is delivered over seven and a half weeks of daily treatments, presenting a burden to patients and the health care system.Stereotactic body radiation (SBRT) is a radiation technique in which large doses are delivered over a short period of time.To date there is extremely limited evidence in SBRT for recurrent prostate cancer after surgery, with a significantly growing body of evidence for…
Read more